Диссертация (Сравнительная оценка средств, облегчающих проявления ксеростомии), страница 20

Evaluation of the levels of oralCandida in patients with Sjogren’s syndrome. Oral Surg Oral Med Oral PatholOral Radiol Endod 1998; 86: 65-8.12980.Aframain D.J. Pilocarpine treatment in a mixed cohort of xerostomic patients /D.J. Aframain, M. Helcer, D. Livni, S.D. Robinson, A. Markitziu & C. Nadler //Oral Diseases. – 2007. - №13(1). – Р. 88-92.81.Almeida P.D.V. Saliva composition and functions: a comprehensive review /P.D.V. Almeida, A.M.T. Gregio, M.A.N.

Machado, A.A.S. Lima, L.R. Azevedo// The Journal of Contemporary Dental Practice. – 2008. – Vol. 9(3). – P.1-11.82.Andersson G., Johansson G., Attstrom R., Edwardsson S., Glantz P.O., LarssonK. Comparison of the effect of the linseed extract Sallinum and a methyl cellulosepreparation on the symptoms of dry mouth / G. Andersson, G. Johansson, R.Attstrom, S. Edwardsson, P.O. Glantz, R. Larsson // Gerodontology. – 1995. –Vol.12. P.12-7.83.Arjan Vissink, James B Mitchell , Bruce J Baum, Kirsten H Limesand, Philip CFox, et.al. Clinical management of salivary gland hypofunction and xerostomia inhead and neck cancer patients: successes and barriers.84.Atkinson JC., Baum Bruce J.

Salivary Enhancement: Current Status and FutureTherapies// Journal of Dental Education, Vol. 65, No. 10.85.Atkinson JC., Fox PC. Salivary gland dysfunction. Clin Geriatr Med 1992; 8:499-511.86.Atkinson JC., Wu AJ. Salivary gland dysfunction. J Am Dent Assoc 1994; 125:409-416.87.Atkinson JC., Wu AJ. Cytokines in the pathogenesis of Sjogren’s syndrome. In:Baum BJ, Cohen MM, eds. Studies in stomatology and craniofacialbiology.Amstedam: IOS Press, 1996: 409-427.88.Baldini C, Talarico R, Tzioufas AG, Bombardieri S. Calssification criteria forSjogren’s syndrome: a critical review. J.

Autoimmun.2012; 39: 9-14.89.Banoczy J. Salivary secretion rate, pH, lactobacilli and yeast counts in diabeticwomen / J. Banoczy, M. Albrecht, O. Rigo, G. Ember, B. Ritlop // Acta DiabetalLat. – 1987. – Vol.24. - №3. – Р.223-228.90.Bentzen J.K. Xerostomia caused by radiotherapy of patients with head and neckcancer / J.K.

Bentzen // Ugeskr. Laeger. – 1992. – Vol.154 (3). – Р.126-129.13091.Bivona P.L. Xerostomia. A common problem among the elderly / P.L. Bivona //N.Y.State Dent.J. – 1998. – Vol.64. - №6 – Р.46-52.92.Blixt-Johansen G. The condition of the oral mucosa in institutionalized elderlypatients before and after using a mucin-containing saliva substitute / G. BlixtJohansen, K. Sjoholm, K.

Wiesel //Scand. J. Caring Sci. – 1992. – Vol. 6(3). - P.147-150.93.Borgnakke WS. Oral and General Health – Exploring the Connection. Dry Mouth(Xerostomia): Diagnosis, Causes, Complications and Treatment Research Review/ W.S. Borgnakke, G.W. Taylor, P.F. Anderson, M.C. Shannon // DDPA. – 2011.– P.1-35.94.Botsios C, Furlan A, Ostuni P, et.al. Elderly onset of primary Sjogren’ssyndrome: clinical manifestations, serological features and oral/ocular diagnostictests. Comparison with adult and young onset of the disease in a cohort of 336Italian patients.

Joint Bone Spine. 2011; 78: 171-17495.Brosky M.E. The Role of Saliva in Oral Health: Strategies for Prevention andMenegment of Xerostomia / M.E. Brosky // J Support Oncol. – 2007. – Vol.5. –Р.215225.96.Cassolato S.F. Xerostomia: clinical aspects and treatment /S.F. Cassolato, R.S.Turnbull // Gerodontology. – 2003. – Vol. 20.

– P. 64-77.97.Challacombe S.J. A clinical score of oral dryness: relation to salivary flow rates/S.J. Challacombe, S.M. Osailan, R. Pramanik, S. Shirodaria, D. Urquhart, S.Masson, G.B. Proctor // J. Dent. Res. - 2008.98.Chung K. Management of Medication Induced Xerostomia. An Evidence BasedReport / K. Chung, P. Fakhri, L. Naderiani, A. Nematullah, P. Salehi // Facultyof Dentistry, University of Toronto, 2008.99.Costa H.J. Is there a relationship between the pH and volume of saliva andesophageal pH-metry results / H.J.

Costa, O.M. Neto, C.A. Eckley // Dysphagia.– 2005. – Vol.20(3). – P.175-181.100. Davies, A. N. A comparison of artificial saliva and pilocarpine in themanagement of xerostomia in patients with advanced cancer / A.N. Davies, C.131Daniels, R. Pugh, K. Sharma // Palliative Medicine. – 1998. – Vol. 12(2). – P.105-111.101. Dawes C. How muth saliva is enough for avoidance of xerostomia / C. Dawes //Caries Research. – 2004. – Vol.38 (3).

– P. 236-240.102. Dirix P. Efficacy of the BioXtra dry mouth care system in the treatment ofradiotherapyinduced xerostomia / P. Dirix, S. Nuyts, V. Vander Poorten, P.Delaere, W. Van den Bogaert // Support Care Cancer. – 2007. – Vol.12. - №15. –P. 1429-36.103. Edgar WM, O’Mullane DM. Saliva and dental health.

London: BDJ, 1990.104. Eliasson L, Birkhed D, Carlen A. Feeling of dry mouth in relation to whole andminor gland saliva secretion rate. Arch Oral Biol. 2009; 54:263-7.105. Forabosco A, Criscuolo M, Coukos G, Uccelli E, Weinstein R, Spinato S, et al.Efficacy of hormone replacement therapy in postmenopausal women with oraldiscomfort.

Oral Surg Oral Med Oral Pathol. 1992; 73:570-4.106. Fox PC, Busch KA, Baum BJ. Subjective reports of xerostomia and objectivemasures of salivary gland performance. J Am Dent Assoc 1987; 115: 581- 4.107. Fox PC. Systemic therapy of salivary gland hypofunction / P.C. Fox // J DentRes.

– 1987. – Vol. 66. – P.689-92.108. Fox P.C. Current concepts of autoimmune exocrinopathy: immunologicmechanisms in the salivary pathology of Sjogren’s syndrome / P.C. Fox, P.M.Speight // Crit Rev Oral Biol Med. – 1996. – Vol. 7(2). – P.144-58.109. Fox P.C. Acquired salivary dysfunction. Drugs and radiation / P.C. Fox // AnnNY Acad. Sci. – 1998. – Vol.842. – P.

132-137.110. Fox RI. Sjogren’s syndrome / P.C. Fox // Lancet. – 2005. Vol. 366(9482). –P.321-31.111. Fox P.C. Oral involvement in primary Sjogren syndrome / P.C. Fox, S.J.Bowman, B. Segal, F.B. Vivino, N. Murukutla, K. Choueiri et al. // J Am DentAssoc. – 2008. – Vol.139(12). – P.1592-601.112. Fox PC. Xerostomia: recognition and management / P.C. Fox// Dent Assist. –2008. Vol. 77(5).

– P.18-20.132113. Fox PC. Differentiation of Dry Mouth Etiology. Adv Dent Res. 1996; 10: 13-16.114. Fox PC., Van der Ven PF, Sonies BC, Weiffenbach J M, Baum BJ. Xerostomia:evaluation of a symptom with increasing significance. J. Am Dent Assoc 1985;110: 519-25.115. Friedlander AH. The physiology, medical management and oral implications ofmenopause. J Am Dent Assoc. 2002; 133: 73-81.116. Frydrych AM. Dry mouth: Xerostomia and salivary gland hypofunction. AustFam Physician. 2016 Jul;45(7):488-92117. Gallardo J.M.

Xerostomia: etiology, diagnosis and treatment / J.M. Gallardo //Rev. Med. Inst. Mex Seguro Soc. – 2008. – Vol.46. - №1. – Р.109-116.118. Glore R.J. A patient with dry mouth / R.J. Glore, K. Spiteri-Staines, V. Paleri //Clin Otolaryngol. – 2009. – Vol. 34(4). – P. 358-63.119. Greenspan D. Xerostomia: diagnosis and management /D. Greenspan //Oncology (Hunting). – 1996. – V.10. - №3. – Р.7-11.120. Gupta A.

Hyposalivation in Elderly Patients / A. Gupta, J. Epstein, H. Sroussi // JCan Dent Assoc. – 2006. – Vol. 72(9). – P.841-6.121. Hamada Т. Treatment of xerostomia with the bile secretionstimulating druganethole trithione: a clinical trial / T. Hamada, T. Nakane, T. Kimura, K.Arisawa, K. Yoneda, T. Yamamoto, T. Osaki // Am. J.

Med. Sci. - 1999.-V.318. №3.- P. 146-151.122. Hendrickson R.G. Pilocarpine toxicity and the treatment of xerostomia / R.G.Hendrickson, A.P. Morocco, M.I. Greenberg // J Emerg Med. – 2004. – Vol.26. –P.42932.123. Laine P. Salivary flow and composition in lymphoma patients before, during andafter treatment with cytostatic drugs / P.

Laine, J. Meurman, L. Nnhovi, J.Tenovuo, H. Murtomaa, C. Lindqvist, S. Pyrhonon, L. Teerenhovi // Eur. J.Cancer B. Oral. Oncol. – 1992. – Vol.28(2). – Р.125-128.124. Mercadante, S. The use of pilocarpine in opioid-induced xerostomia / S.Mercadante, L. Calderone, P. Villari, R. Serretta., M. Sapio, A. Casuccio et al. //Palliative Medicine. – 2000. – Vol.

14(6). – P. 529-531.133125. Nagy G. Use of hydroxy-propyl-methyl cellulose (methocel) and carboxy-methylcellulose containing artificial saliva in the symptomatic treatment of xerostomia /G. Nagy, E. Olveti, M. Zeher, S. Marton, G. Keszthelyi // Fogorv Sz. -1995. –Vol.88(9). – P. 299304.126. Narhi T.O. Prevalence of subjective feelings of dry mouth in the elderly / T.O.Narhi // J Dent Res. 1994. – Vol. 73(1). – P.20-5.127. Narhi T.O., Meurman J.H., Ainamo A. Xerostomia and hyposalivation: causes,consequences and treatment in the elderly / T.O. Narhi, J.H.

Meurman, A.Ainamo // Drugs Aging. – 1999. Vol. 15. – P. 103-106.128. Ohqa N, Yamazaki Y, Sato J, Asaka T, Morimoto M, Hata H, Satoh C, KitaqawaY. Elimination of candidiasis may increase stimulated whole salivary flow rate.Arch Oral Biol. 2016 Aug 3;71:129-133.129. Porter S.R. An update of the etiology and manadement of xerostomia / S.R.Porter, C. Scully, A.M. Hegarty // Oral Surgery, Oral Medicine, Oral Pathology,Oral Radiology, and Endodontics. – 2004.

Vol. - 97(1). – P. 28-46.130. Ritter A.V. Xerostomia (dry mouth) / A.V. Ritter // J Esthet Restor Dent. – 2006.– Vol. 18(5). – P. 306.131. Scully C. Drug effects on salivary glands: dry mouth / С. Scully // Oral Diseases.– 2003. Vol. 9. – P. 165-176.132. Sreebny L.M. Xerostomia in diabetes mellitus / L.M. Sreebny, A. Green, A.Valdini, A. Yu // Diabetes Care. – 1992. – V.15. - №7.

– Р. 900-904.133. Sreebny L.M. Dry mouth, the malevolent symptom: a clinical guide / L.M.Sreebny, A. Vissink et al. // Singapore: Wiley-Blackwell. – 2010. - P. 268.134. Thomas B.L. Salivary gland disease / B.L. Thomas, J.E. Brown, M. McGurk //Front Oral Biol. – 2010. Vol. 14. – P. 129-46.135.

Thomson W.M. The impact of xerostomia on oral-health-related quality of lifeamong younger adults / W.M.Thomson, H.P.Lawrence, J.M.Broadbent,R.Poulton // Health Qual. Life Outcomes. – 2006. – Vol.4. – P.86.136. Thomson WМ, Poulton R, Mark Broadbent J, Al-Kubaisy S. Xerostomia andmedications among 32-years-olds / W.M. Thomson, R. Poulton, J. Mark134Broadbent, S. AlKubaisy // Acta Odontol Scand. – 2006. – Vol.64(4). – P. 24954.137. Thomson W.M. Issues in the epidemiological investigation of dry mouth / W.M.Thomson // Gerodontology.

– 2005. – Vol. 22 (2). – P. 65-76.138. Turner M.D., Ship J.A. Dry mouth and its effects on the health of elderly people /M.D. Turner, J.A. Ship // J Am Dent Assoc. – 2008. – Vol.139. - №3. – Р.252253.139. Wick J.Y. Xerostomia: causes and treatment / J.Y. Wick // Consult Pharm. –2007. – Vol.22.

- № 12. – Р.985-992.140. Wiener R.C. Hiposalivation and xerostomia in dentale older adults / R.C. Wiener,B. Wu, R. Crout, M. Wiener, B. Plassman, E. Kao, D. McNeil // JADA. – 2012. –Vol. 141(3). - Р. 279-284..